There's a little more risk in the market, and that has one pro feeling less bullish.» Read More
The outlook for biotech is "wonderful," explains Sam Isaly, Orbimed Advisors managing partner.
Agios CEO David Schenkein on a new approach to cancer, and the outlook for product approval, from the JPMorgan Health Care Conference in San Francisco.
Accuray CEO Joshua Levine talks to CNBC's Brian Sullivan about his company's history of innovation and how it deals with larger competitors.
Target disclosed that a mass information breach involved data belonging to up to 70 million customers.
Discussing current market action and what it signals about economic growth, with James Paulsen, Wells Capital Management CIO, and Linda Duessel, Federated Investors.
Digging into the financials of various retailers, including Five Below and Sears, with Jan Kniffen, CEO of Worldwide Enterprises, and Herb Greenberg of TheStreet.com.
Alnylam CEO John Maraganore talks to Brian Sullivan about today's big announcement of a huge investment in the company by Genzyme. From the JPM Health Care Conference in San Francisco.
Brian asks InterMune Chairman, President and CEO Dan Welch for an update on its drug Esbriet, and chances for U.S. approval.
Target says 70 million Target shoppers have had their names, emails, addresses and phone numbers stolen during November 27th and December 15th. Faye Landes, Cowen & Co.; Scott Schober, Berkeley Varitronics Systems CEO; and Jan Kniffen, J. Rogers Kniffen CEO, provide perspective.
CNBC's Brian Sullivan predicts a lackluster year for the Dow but has his eye on Mexico's stock market.
Arena Co-Founder, Chairman, President and CEO Jack Lief talks to CNBC's Brian Sullivan about strategies for increasing weight-loss drug Belviq's prescriptions, from the JPM Health Care Conference in San Francisco.
A new study reveals that 80 percent of Super Bowl spots don't help sales. Pop culture commentator Chuck Nice shares his opinions on three hot topics.
CNBC's Simon Hobbs speaks with Royal Caribbean Cruises Chairman & CEO Richard Fain about how he keeps his business afloat amid controversy.
Bill Gross, Pimco founder & co-CIO, discusses its index products, and where it¿s putting its money in equities.
Bill Gross, Pimco founder & co-CIO, explains why he likes the Mexican peso.
Shares of Intercept Pharmaceuticals are up more than 560 percent this week alone. Akiva Felt, Oppenheimer senior analyst, shares his optimistic view for the company.
CNBC's Robert Frank reports on where the wealthy are fleeing for warm weather.
Nicole Miller Regan, Piper Jaffray, and R.J. Hottovy, Morningstar, share their top restaurant stock picks, including Starbucks and Yum! Brands.
CNBC's Sharon Epperson provides Thursday's daily check of gasoline prices in the U.S.
The Athens Composite is up 11 percent year-to-date. CNBC's Michelle Caruso-Cabrera discusses the country's reduction in its government size, as well as cuts in salaries, and why its economy is doing well.